ATE179885T1 - Pharmazeutisches trägersystem, das definierte lipide enthält - Google Patents
Pharmazeutisches trägersystem, das definierte lipide enthältInfo
- Publication number
- ATE179885T1 ATE179885T1 AT93908232T AT93908232T ATE179885T1 AT E179885 T1 ATE179885 T1 AT E179885T1 AT 93908232 T AT93908232 T AT 93908232T AT 93908232 T AT93908232 T AT 93908232T AT E179885 T1 ATE179885 T1 AT E179885T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- carrier system
- system containing
- pharmaceutical carrier
- lipid
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9200952A SE9200952D0 (sv) | 1992-03-27 | 1992-03-27 | Pharmaceutical carrier system containing defined lipids |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE179885T1 true ATE179885T1 (de) | 1999-05-15 |
Family
ID=20385758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93908232T ATE179885T1 (de) | 1992-03-27 | 1993-03-26 | Pharmazeutisches trägersystem, das definierte lipide enthält |
Country Status (10)
Country | Link |
---|---|
US (1) | US5635205A (de) |
EP (1) | EP0636020B1 (de) |
JP (1) | JPH07508708A (de) |
AT (1) | ATE179885T1 (de) |
DE (1) | DE69324914T2 (de) |
DK (1) | DK0636020T3 (de) |
FI (1) | FI114140B (de) |
NO (1) | NO308984B1 (de) |
SE (1) | SE9200952D0 (de) |
WO (1) | WO1993019736A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5665379A (en) * | 1990-09-28 | 1997-09-09 | Pharmacia & Upjohn Aktiebolag | Lipid particle forming matrix, preparation and use thereof |
SE9402453D0 (sv) * | 1994-07-12 | 1994-07-12 | Astra Ab | New pharmaceutical preparation |
DE4447287C1 (de) * | 1994-12-30 | 1996-11-07 | Cevc Gregor | Präparat zum Wirkstofftransport durch Barrieren |
ES2138130T3 (es) * | 1995-10-28 | 2000-01-01 | Braun Melsungen Ag | Composicion farmaceutica que contiene un anestesico local y/o un analgesico de accion central. |
JP2001524958A (ja) * | 1997-04-17 | 2001-12-04 | ジーエス ディベロップメント アクティエボラーグ | 新規な液晶をベースとする生物接着性薬剤送出系 |
JP4467789B2 (ja) | 1997-09-18 | 2010-05-26 | パシラ ファーマシューティカルズ インコーポレーテッド | 持続放出性リポソーム麻酔組成物 |
IL135989A0 (en) | 1997-11-14 | 2001-05-20 | Skyepharma Inc | Processes for the production of multivesicular liposomes |
AU752225B2 (en) | 1998-07-17 | 2002-09-12 | Pacira Pharmaceuticals, Inc. | Biodegradable compositions for the controlled release of encapsulated substances |
CN1320880C (zh) | 1998-12-23 | 2007-06-13 | 伊迪亚股份公司 | 改进的体内局部无创伤用制剂 |
SE0000730D0 (sv) * | 2000-03-06 | 2000-03-06 | Scotia Holdings Plc | Lipid carrier |
AU2002322024B2 (en) * | 2001-05-31 | 2008-05-08 | Pacira Pharmaceuticals, Inc. | Encapsulation of nanosuspensions in liposomes and microspheres |
EP2209450A4 (de) | 2007-11-07 | 2013-09-25 | Svip5 Llc | Langsame freisetzung von organischen salzen von lokalanästhetika zur schmerzlinderung |
WO2011121034A2 (en) | 2010-04-01 | 2011-10-06 | Pharmanest Ab | Water-free pharmaceutical compositions suitable for local anaesthetics |
US9668974B2 (en) | 2012-05-10 | 2017-06-06 | Painreform Ltd. | Depot formulations of a local anesthetic and methods for preparation thereof |
AU2014223993B2 (en) | 2013-02-28 | 2016-09-08 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid formulations and its compostions |
US10220093B2 (en) | 2013-02-28 | 2019-03-05 | Mira Pharma Corporation | Long-acting semi-solid lipid formulations |
US10561606B2 (en) | 2017-12-06 | 2020-02-18 | Mira Pharma Corporation | Injectable long-acting local anesthetic semi-solid gel formulations |
US11426418B2 (en) | 2017-12-06 | 2022-08-30 | Mira Pharma Corporation | Injectable long-acting semi-solid gel formulations |
US11033495B1 (en) | 2021-01-22 | 2021-06-15 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
US11357727B1 (en) | 2021-01-22 | 2022-06-14 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
US11278494B1 (en) | 2021-01-22 | 2022-03-22 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8613811D0 (en) * | 1986-06-06 | 1986-07-09 | Phares Pharm Res Nv | Composition & method |
EP0158441B2 (de) * | 1984-03-08 | 2001-04-04 | Phares Pharmaceutical Research N.V. | Liposombildende Zusammensetzung |
US5059421A (en) * | 1985-07-26 | 1991-10-22 | The Liposome Company, Inc. | Preparation of targeted liposome systems of a defined size distribution |
SE9003100D0 (sv) * | 1990-09-28 | 1990-09-28 | Kabivitrum Ab | Lipid formulation system |
-
1992
- 1992-03-27 SE SE9200952A patent/SE9200952D0/xx unknown
-
1993
- 1993-03-26 EP EP93908232A patent/EP0636020B1/de not_active Expired - Lifetime
- 1993-03-26 AT AT93908232T patent/ATE179885T1/de not_active IP Right Cessation
- 1993-03-26 JP JP5517360A patent/JPH07508708A/ja active Pending
- 1993-03-26 DE DE69324914T patent/DE69324914T2/de not_active Expired - Fee Related
- 1993-03-26 WO PCT/SE1993/000257 patent/WO1993019736A1/en active IP Right Grant
- 1993-03-26 DK DK93908232T patent/DK0636020T3/da active
- 1993-03-26 US US08/307,761 patent/US5635205A/en not_active Expired - Fee Related
-
1994
- 1994-09-23 NO NO943543A patent/NO308984B1/no not_active IP Right Cessation
- 1994-09-26 FI FI944441A patent/FI114140B/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI944441A0 (fi) | 1994-09-26 |
SE9200952D0 (sv) | 1992-03-27 |
FI944441A (fi) | 1994-09-26 |
DK0636020T3 (da) | 1999-11-15 |
WO1993019736A1 (en) | 1993-10-14 |
FI114140B (fi) | 2004-08-31 |
US5635205A (en) | 1997-06-03 |
NO943543D0 (no) | 1994-09-23 |
EP0636020A1 (de) | 1995-02-01 |
EP0636020B1 (de) | 1999-05-12 |
NO943543L (no) | 1994-09-23 |
JPH07508708A (ja) | 1995-09-28 |
DE69324914T2 (de) | 1999-12-09 |
NO308984B1 (no) | 2000-11-27 |
DE69324914D1 (de) | 1999-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE179885T1 (de) | Pharmazeutisches trägersystem, das definierte lipide enthält | |
DK398587D0 (da) | Antitumorvirksomt laegemiddel | |
GB2146526B (en) | Preparations for the transdermal application of active substances | |
GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
KR920019342A (ko) | 골질환 치료제 | |
AU5431390A (en) | Novel arylpyridazines, their manufacture, use and medicaments containing them | |
ES2039203T3 (es) | Composicion de liposomas. | |
KR950028767A (ko) | 피부통과 투약을 위한 신규의 약제학적 투여 형태 | |
DK0615443T3 (da) | Lægemiddel i akut virksom form indeholdende Flurbiprofen og anvendelse deraf | |
ATE137959T1 (de) | Liposomale piroxycam formulierung | |
ES2086538T3 (es) | Medicamento para el tratamiento de la hiperlipemia y/o aterosclerosis. | |
FR2362849A1 (fr) | Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant | |
MC1930A1 (fr) | Produit antiviral | |
ES511097A0 (es) | "procedimiento para la preparacion de derivados de oxindol". | |
DE69112573D1 (de) | Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält. | |
SE8302580D0 (sv) | Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning | |
ES2122962T3 (es) | Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia. | |
MX9302986A (es) | Medicamento que contiene metrifonato y procedimiento para su preparacion | |
FR2681247B1 (fr) | Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation. | |
CA2036592A1 (en) | Therapeutic agent for diabetic gangrene | |
KR890000089A (ko) | 신장 질환 치료제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEIH | Change in the person of patent owner | ||
UEP | Publication of translation of european patent specification | ||
EEIH | Change in the person of patent owner | ||
REN | Ceased due to non-payment of the annual fee |